Building an R community - Learnings from AZ
In this new episode, I and Guillaume Desachy delve into the world of R and its impact on the pharmaceutical industry. Guillaume, a Statistical Science Director at AstraZeneca in Sweden, shares his insights and experiences in fostering an R community within the company.
Embarking on the exploration of Guillaume's journey in building the R at AstraZeneca community beckons a series of intriguing questions:
How does a modest idea transform into a community boasting over 1,600 collaborators within just three years?
What challenges and decisions shape the trajectory of such a community, leading to the retirement of initiatives like AZTidyTuesday?
How does the community navigate the intricate balance between growth and sustaining valuable initiatives?
We also talk about the following key points: